Eli Lilly and Company (LLY)-Medical Equipment-Deals and Alliances Profile

Eli Lilly and Company (LLY)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME4003D
  • |
  • Pages: 94
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Eli Lilly and Company (Lilly) is a healthcare company that discovers, develops and markets human and animal healthcare products. The company offers medicines for cardiovascular conditions, diabetes, cancer, neurological problems, critical care, men's health and musculoskeletal problems. It also provides pet medicine, food-safety products and companion animal health products, besides services to the food animal industry. Lilly also has mid-to-late stage pipeline portfolio for conditions such as diabetes, cancer, neurological problems and autoimmune disorders. The company distributes human pharmaceutical and animal health products through independent wholesale distributors. It also promotes its products through sales representatives and marketing agreements with other pharmaceutical companies. The company offers its products in the US, Europe, Japan and Other foreign countries. Lilly is headquartered in Indianapolis, Indiana, the US.

Eli Lilly and Company (LLY)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Eli Lilly and Company, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Eli Lilly and Company, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Eli Lilly and Company, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Eli Lilly and Company, Medical Equipment, Deals By Market, 2011 to YTD 2017 9

Eli Lilly and Company, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Eli Lilly and Company, Medical Equipment, Deal Details 12

Asset Purchase 12

Eli Lilly Acquires Two Alzheimer's Disease Imaging Agents From Siemens Medical Solutions 12

Venture Financing 13

Veritas Genetics Raises USD30 Million in Series B Financing 13

Millin Enterprises Raises Funds through Series A financing 14

ACEA Biosciences Raises USD30 Million in Venture Financing 14

Microtech Medical Raises Funds through Series A Financing 15

Veritas Genetics Raises USD10 Million in Series A Financing Round 16

Companion Medical Raises USD3.15 Million in Series B Financing 16

Partnerships 17

Insulet Enters into Co-Development Agreement with Eli Lilly 17

Qiagen Enters into Co-Development Agreement with Eli Lilly for Companion Diagnostic Test 18

Qiagen And Eli Lilly Enter Into Co-Development Agreement For Companion Diagnostic Test 19

Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker 20

Corgenix Enters Into Co-Development Agreement With Eli Lilly 21

Insulet Enters Into Co-Development Agreement With Eli Lilly 22

Qiagen Enters Into Co-Development Agreement With Eli Lilly 22

Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests 23

PrimeraDx Enters Into Co-Development Agreement With Eli Lilly 24

Cardinal Health Enters Into Co-Marketing Agreement With Eli Lilly For Amyvid 25

PETNET Solutions Enters Into Distribution Agreement With Eli Lilly and Company 26

QIAGEN Enters Into Co-Development Agreement With Eli Lilly 27

Synthes Enters Into Co-Development Agreement With Eli Lilly 28

Eli Lilly Enters Into Collaboration With Medtronic 28

Eli Lilly and Company-Key Competitors 30

Key Employees 31

Locations And Subsidiaries 33

Head Office 33

Other Locations & Subsidiaries 33

Recent Developments 43

Financial Announcements 43

Apr 25, 2017: Lilly Reports First-Quarter 2017 Results 43

Jan 31, 2017: Lilly Reports Fourth-Quarter And Full-Year 2016 Results 47

Dec 15, 2016: Lilly Provides 2017 Financial Guidance And 2016 Update, Reaffirms Financial Expectations Through The Remainder Of The Decade 53

Oct 25, 2016: Lilly Reports Third-Quarter 2016 Results 55

Jul 26, 2016: Lilly Reports Second-Quarter 2016 Results, Provides Financial Expectations Through The Remainder Of The Decade 59

Apr 26, 2016: Lilly Reports First-Quarter 2016 Results, Revises 2016 Financial Guidance 63

Jan 28, 2016: Lilly Reports Fourth-Quarter And Full-Year 2015 Results 67

Corporate Communications 73

Jun 01, 2017: Derica Rice To Retire As Lilly Chief Financial Officer 73

May 10, 2017: Leigh Ann Pusey Joins Lilly as Senior Vice President of Corporate Affairs and Communications 74

Mar 02, 2017: Lilly Announces Changes In Senior Management 75

Feb 09, 2017: Carolyn R. Bertozzi, Ph.D., Elected To Lilly Board Of Directors 76

Sep 14, 2016: Levi Garraway, M.D., Ph.D., to become Senior Vice President of Global Oncology at Lilly, Succeeding Richard Gaynor, M.D., Who is Retiring after a Distinguished Career 77

Aug 31, 2016: Jamere Jackson Elected To Lilly Board Of Directors 78

Aug 10, 2016: Lilly announces Joshua Smiley, Anat Ashkenazi appointed to new roles, Thomas Grein retires 79

Jul 27, 2016: John C. Lechleiter to Retire as Lilly CEO; Board Elects David A. Ricks as Successor 80

Jun 13, 2016: Aarti Shah named chief information officer 82

Government and Public Interest 83

Apr 04, 2017: Lilly and Ohio University Heritage College of Osteopathic Medicine Partner on Rotation Program for Medical Students 83

Product News 84

Jul 27, 2016: New Studies Suggest Relationship Between Tau Pathology And Progression Of Alzheimer's Disease 84

Other Significant Developments 86

Jun 21, 2017: Eli Lilly And Company Unveils Expanded Biotechnology Center In San Diego 86

Jan 05, 2017: Lilly To Adjust Organization And Leadership Structure To Better Align With Growth Opportunities 88

Oct 17, 2016: Lilly Partners with the National Cancer Institute to Accelerate Cancer Research through New Program under Cancer Moonshot Initiative 90

Jun 17, 2016: Lilly Launches Domestic Production of Entire Range of Humulin, Humalog Insulins and Long Acting Insulin Analogue in partnership with R-Pharm Group 91

May 24, 2016: Lilly Details Robust R&D Pipeline to Investment Community 92

Feb 24, 2016: Indiana Biosciences Research Institute Announces $100 Million in Grants Supporting Scientific Innovation to Address Metabolic Disease and Poor Nutrition 93

Appendix 94

Methodology 94

About GlobalData 94

Contact Us 94

Disclaimer 94

List of Figures

Eli Lilly and Company, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Eli Lilly and Company, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Eli Lilly and Company, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Eli Lilly and Company, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Eli Lilly and Company, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Eli Lilly and Company, Medical Equipment, Deals by Type, 2011 to YTD 2017 7

Eli Lilly and Company, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Eli Lilly and Company, Medical Equipment, Deals by Market, 2011 to YTD 2017 9

List of Tables

Eli Lilly and Company, Medical Equipment, Key Facts, 2016 1

Eli Lilly and Company, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Eli Lilly and Company, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Eli Lilly and Company, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Eli Lilly and Company, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Eli Lilly and Company, Deals By Market, 2011 to YTD 2017 9

Eli Lilly and Company, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Eli Lilly Acquires Two Alzheimer's Disease Imaging Agents From Siemens Medical Solutions 12

Veritas Genetics Raises USD30 Million in Series B Financing 13

Millin Enterprises Raises Funds through Series A financing 14

ACEA Biosciences Raises USD30 Million in Venture Financing 14

Microtech Medical Raises Funds through Series A Financing 15

Veritas Genetics Raises USD10 Million in Series A Financing Round 16

Companion Medical Raises USD3.15 Million in Series B Financing 16

Insulet Enters into Co-Development Agreement with Eli Lilly 17

Qiagen Enters into Co-Development Agreement with Eli Lilly for Companion Diagnostic Test 18

Qiagen And Eli Lilly Enter Into Co-Development Agreement For Companion Diagnostic Test 19

Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker 20

Corgenix Enters Into Co-Development Agreement With Eli Lilly 21

Insulet Enters Into Co-Development Agreement With Eli Lilly 22

Qiagen Enters Into Co-Development Agreement With Eli Lilly 22

Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests 23

PrimeraDx Enters Into Co-Development Agreement With Eli Lilly 24

Cardinal Health Enters Into Co-Marketing Agreement With Eli Lilly For Amyvid 25

PETNET Solutions Enters Into Distribution Agreement With Eli Lilly and Company 26

QIAGEN Enters Into Co-Development Agreement With Eli Lilly 27

Synthes Enters Into Co-Development Agreement With Eli Lilly 28

Eli Lilly Enters Into Collaboration With Medtronic 28

Eli Lilly and Company, Key Competitors 30

Eli Lilly and Company, Key Employees 31

Eli Lilly and Company, Subsidiaries 33

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Eli Lilly and Company, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16863
Site License
USD 500 INR 33725
Corporate User License
USD 750 INR 50588

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com